Accelerate Diagnostics
AXDX
#10555
Rank
A$1.2 M
Marketcap
A$0.04775
Share price
0.00%
Change (1 day)
-97.16%
Change (1 year)

Earnings for Accelerate Diagnostics (AXDX)

Earnings in 2024 (TTM): -A$55.8 Million

According to Accelerate Diagnostics's latest financial reports the company's current earnings are A$11.69 Million. , an increase over its 2023 earnings that were of -A$74.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Accelerate Diagnostics from 1998 to 2024

Annual earnings

Year Earnings Change
2024 -A$51.96 Million-30.23%
2023 -A$74.47 Million-10.11%
2022 -A$82.84 Million-5.02%
2021 -A$87.23 Million-0.87%
2020 -A$87.99 Million-10.7%
2019 -A$98.53 Million-10.05%
2018 -A$0.11 Billion22.77%
2017 -A$89.23 Million-4%
2016 -A$92.94 Million47.64%
2015 -A$62.95 Million42.74%
2014 -A$44.11 Million105.26%
2013 -A$21.49 Million
2011 -A$1.67 Million-182.9%
2010 A$2 M-219.16%
2009 -A$1.69 Million6.65%
2008 -A$1.59 Million-40.67%
2007 -A$2.67 Million14.69%
2006 -A$2.33 Million399.94%
2005 -A$0.47 Million
2001 -A$1.62 Million-52.29%
2000 -A$3.38 Million53.4%
1999 -A$2.21 Million-282.93%
1998 A$1.2 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
A$9.96 B-19,280.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$2.64 B-5,187.17%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
A$0.66 B-1,382.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
A$0.10 B-301.65%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-A$0.23 Billion 328.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-A$1.19 Billion 2,177.65%๐Ÿ‡บ๐Ÿ‡ธ USA